HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parlux Fragrances

This article was originally published in The Rose Sheet

Executive Summary

Net sales for fiscal year ended March 31 increased 3.8% to $68.9 mil., largely due to new distribution, Fort Lauderdale, Fla. firm says. Sales to "unrelated" customers were up 29%, while sales to related parties decreased 27% during the year, confirming "acceptance of our products in both domestic and international markets," firm says. Net income rose 1.4% for the year to $3.9 mil. Fourth quarter net sales fell 2% to $14.8 mil. and net income dropped 34.7% to $620,000. Parlux holds fragrance licenses to Perry Ellis, Fred Hayman Beverly Hills and Ocean Pacific. Company recently launched new fragrance line, Physical, under Jockey brand (1"The Rose Sheet" April 30, p. 6)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009353

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel